Latest period
$1.37B
YoY change
+15.1%
5Y CAGR
+6.1%
Peak year (2025)
$1.35B
Latest annual
$1.35B
Stock-Based Compensation history chart for Johnson & Johnson (JNJ) from 1989 to 2025
Latest: $1.35B
Stock-Based Compensation growth chart for Johnson & Johnson (JNJ) from 1989 to 2025
Latest: +15.1%
Stock-Based Compensation history table for Johnson & Johnson (JNJ) from 1989 to 2025
| 2025 | $1.35B | +15.1% | +$178.00M | ||
| 2024 | $1.18B | +1.2% | +$14.00M | ||
| 2023 | $1.16B | +2.1% | +$24.00M | ||
| 2022 | $1.14B | +0.3% | +$3.00M | ||
| 2021 | $1.14B | +12.9% | +$130.00M | ||
| 2020 | $1.00B | +2.9% | +$28.00M | ||
| 2019 | $977.00M | -0.1% | −$1.00M | ||
| 2018 | $978.00M | +1.7% | +$16.00M | ||
| 2017 | $962.00M | +9.6% | +$84.00M | ||
| 2016 | $878.00M | +0.5% | +$4.00M | ||
| 2015 | $874.00M | +10.4% | +$82.00M | ||
| 2014 | $792.00M | +8.8% | +$64.00M | ||
| 2013 | $728.00M | +10.0% | +$66.00M | ||
| 2012 | $662.00M | +6.6% | +$41.00M | ||
| 2011 | $621.00M | +1.1% | +$7.00M | ||
| 2010 | $614.00M | -2.2% | −$14.00M | ||
| 2009 | $628.00M | +0.2% | +$1.00M | ||
| 2008 | $627.00M | -10.2% | −$71.00M | ||
| 2007 | $698.00M | — | +$698.00M | ||
| 2006 | $0.00 | — | $0.00 | ||
| 2005 | $0.00 | — | $0.00 | ||
| 2004 | $0.00 | — | $0.00 | ||
| 2003 | $0.00 | — | $0.00 | ||
| 2002 | $0.00 | — | $0.00 | ||
| 2001 | $0.00 | — | $0.00 | ||
| 2000 | $0.00 | — | $0.00 | ||
| 1999 | $0.00 | — | $0.00 | ||
| 1998 | $0.00 | — | $0.00 | ||
| 1997 | $0.00 | — | $0.00 | ||
| 1996 | $0.00 | — | $0.00 | ||
| 1995 | $0.00 | — | $0.00 | ||
| 1994 | $0.00 | — | $0.00 | ||
| 1993 | $0.00 | — | $0.00 | ||
| 1992 | $0.00 | — | $0.00 | ||
| 1991 | $0.00 | — | $0.00 | ||
| 1990 | $0.00 | — | $0.00 | ||
| 1989 | $0.00 | — | — |
- 2025$1.35B+15.1%
- 2024$1.18B+1.2%
- 2023$1.16B+2.1%
- 2022$1.14B+0.3%
- 2021$1.14B+12.9%
- 2020$1.00B+2.9%
- 2019$977.00M-0.1%
- 2018$978.00M+1.7%
- 2017$962.00M+9.6%
- 2016$878.00M+0.5%
- 2015$874.00M+10.4%
- 2014$792.00M+8.8%
- 2013$728.00M+10.0%
- 2012$662.00M+6.6%
- 2011$621.00M+1.1%
- 2010$614.00M-2.2%
- 2009$628.00M+0.2%
- 2008$627.00M-10.2%
- 2007$698.00M—
- 2006$0.00—
- 2005$0.00—
- 2004$0.00—
- 2003$0.00—
- 2002$0.00—
- 2001$0.00—
- 2000$0.00—
- 1999$0.00—
- 1998$0.00—
- 1997$0.00—
- 1996$0.00—
- 1995$0.00—
- 1994$0.00—
- 1993$0.00—
- 1992$0.00—
- 1991$0.00—
- 1990$0.00—
- 1989$0.00—
Stock-Based Compensation values are taken from Johnson & Johnson's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Johnson & Johnson (JNJ)
Stock-Based Compensation for Johnson & Johnson (JNJ): headline value $1.37B · YoY +15.1%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual stock-based compensation for Johnson & Johnson (JNJ) came in at $1.35B – grew 15.1% year-over-year.
Johnson & Johnson stock-based compensation has grown on net over the period, with a +6.1% compound annual growth rate over 2020–2025 (5 years).
The highest annual stock-based compensation of $1.35B was reported in 2025. The lowest in the available history was $0.00 in 1989.
Johnson & Johnson Stock-Based Compensation by Year
Johnson & Johnson Stock-Based Compensation 2025: $1.35B
Johnson & Johnson stock-based compensation in 2025 was $1.35B, grew 15.1% from 2024. This figure represents the highest annual value in the available history.
Johnson & Johnson Stock-Based Compensation 2024: $1.18B
2024's stock-based compensation for Johnson & Johnson came in at $1.18B, edged up 1.2% from 2023.
Johnson & Johnson Stock-Based Compensation 2023: $1.16B
Johnson & Johnson posted stock-based compensation of $1.16B in 2023, edged up 2.1% from 2022.
Johnson & Johnson Stock-Based Compensation 2022: $1.14B
In 2022, Johnson & Johnson reported stock-based compensation of $1.14B, edged up 0.3% from 2021.
Johnson & Johnson Stock-Based Compensation 2021: $1.14B
Johnson & Johnson stock-based compensation in 2021 was $1.14B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers by Stock-Based Compensation
Healthcare peers of Johnson & Johnson (JNJ), ranked by their latest stock-based compensation
| $971.00M | |
| $955.00M | |
| $626.00M | |
| $310.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $971.00M
- $955.00M
- $626.00M
- $310.00M
- $0.00
- $0.00
- $0.00
- $0.00
Frequently asked questions
Johnson & Johnson (JNJ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation